Page 1 of 1
(b) Bevacizumab is an antibody that exhibits anti-cancer activity by binding to vascular endothelial growth factor (VEGF
Posted: Thu Jun 09, 2022 11:11 am
by answerhappygod
- B Bevacizumab Is An Antibody That Exhibits Anti Cancer Activity By Binding To Vascular Endothelial Growth Factor Vegf 1 (30.3 KiB) Viewed 48 times
(b) Bevacizumab is an antibody that exhibits anti-cancer activity by binding to vascular endothelial growth factor (VEGF). What are the main constraints in formulating this therapeutic biomolecule for injection? When answering, consider the chemical, physical and biological properties of antibodies and how these might be affected by the practical requirements for injectable formulations. [12 marks; word limit = 300]